Researchers unveiled the first integrated single-cell atlas of human atherosclerotic plaques, revealing cellular heterogeneity and molecular pathways underpinning this leading cause of cardiovascular disease. The atlas provides invaluable insights into plaque microenvironments and targets for therapeutic intervention. This advancement, leveraging high-throughput single-cell technologies, offers a new framework for understanding disease progression and identifying precision medicine strategies to combat atherosclerosis.